- Home
- PLRX vs NA Comparison
PLRX vs NA Comparison
Compare PLRX & NA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLRX | NA |
|---|---|---|
| Founded | 2015 | 2019 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 93.3M | 98.5M |
| IPO Year | 2020 | 2022 |
Fundamental Metrics
Financial Performance| Metric | PLRX | NA |
|---|---|---|
| Price | $1.53 | $4.11 |
| Analyst Decision | Hold | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $3.79 | N/A |
| AVG Volume (30 Days) | ★ 762.4K | 104.1K |
| Earning Date | 11-06-2025 | 08-15-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $3,369,693.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.10 | $3.33 |
| 52 Week High | $15.80 | $31.48 |
Technical Indicators
Market Signals| Indicator | PLRX | NA |
|---|---|---|
| Relative Strength Index (RSI) | 42.21 | 40.46 |
| Support Level | $1.48 | $4.10 |
| Resistance Level | $1.63 | $4.39 |
| Average True Range (ATR) | 0.10 | 0.33 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 10.45 | 3.30 |
Price Performance
Historical ComparisonAbout PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
About NA Nano Labs Ltd
Nano Labs Ltd operates as a fabless IC design company and product solution provider in China. It engages in the development of HTC chips, HPC chips, distributed computing and storage solutions, smart-NICs, vision computing chips, and distributed rendering. Its products comprise Cuckoo 1.0 Chip, Cuckoo 2.0 Chip, and Darkbird 1.0 Chip. Majority of the company revenue comes from China.